FDA Approves New Drug to Treat HIV, AIDS
The Food and Drug Administration has approved efavirenz, a new drug, to treat HIV and AIDS in children and adults. Efavirenz, in combination with other antiretroviral agents, was approved to treat HIV-1 infection after 24-week studies showed it to be effective in suppressing HIV.
Efavirenz is to be taken just once daily which can be beneficial to people who are being treated with drug combination therapy. It is the third class of drugs known as nonnucleoside reverse transcriptase inhibitor approved by the FDA.
Dupont Pharmaceuticals manufactures efavirenz under the trade name Sustiva. To view the FDAs press release, click here.
Posted 9/29/98Source FDA